文献速递产科

引产中高剂量与低剂量缩宫素方案的比较:系统综述与荟萃分析

High- vs low-dose oxytocin protocols for labor induction: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-05-05

该系统综述与荟萃分析纳入6项研究(2项随机对照试验、4项观察性研究),共7850例分娩,比较高剂量与低剂量缩宫素引产方案。高剂量组与低剂量组剖宫产率无差异(26.0% vs 28.4%,合并RR 1.02,95%CI 0.85-1.21),高剂量组产后出血频率较低(7.6% vs 9.9%,RR 0.78,95%CI 0.66-0.92)。作者指出现有研究存在方法学局限,需要高质量试验指导最佳缩宫素剂量。

要点

  • 高剂量与低剂量缩宫素引产的剖宫产风险无差异(26.0% vs 28.4%,合并RR 1.02,95%CI 0.85-1.21)。
  • 高剂量缩宫素引产与较低的产后出血频率相关(7.6% vs 9.9%,RR 0.78,95%CI 0.66-0.92)。
  • 纳入研究均为中等或高偏倚风险,高、低剂量方案细节差异大,需高质量试验指导最佳剂量。

核心结论

  • 现有文献综合显示,高剂量与低剂量缩宫素引产方案的剖宫产频率无差异。
  • 本综述凸显了现有少量已发表研究的方法学局限性,以及需要高质量试验来指导引产的最佳缩宫素剂量。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase、Scopus、CINAHL、Cochrane数据库及ClinicalTrials.gov,检索时间从建库至2023年1月17日。
  • 纳入比较低剂量(起始0.5-2毫单位/分钟,每15-40分钟增加1-2毫单位/分钟)与高剂量(≥4毫单位/分钟,每15-40分钟增加3-6毫单位/分钟)缩宫素引产方案的随机或观察性研究,排除胎儿死亡者。
  • 共纳入6项研究(2项随机对照试验、4项观察性研究),涵盖7850例分娩(高剂量组3957例,低剂量组3893例)。
  • 两名评价者独立提取数据并按PRISMA指南及Cochrane偏倚风险评估工具评价研究质量。

主要发现

  • 高剂量组与低剂量组剖宫产率分别为26.0%与28.4%,合并RR 1.02(95%CI 0.85-1.21),无差异。
  • 因胎儿状态不良而剖宫产的可能性及新生儿发病率无差异,引产持续时间亦无差异。
  • 高剂量缩宫素引产与较低的产后出血频率相关(7.6% vs 9.9%,RR 0.78,95%CI 0.66-0.92)。
  • 高、低剂量方案细节在研究间差异很大,所有研究均为中等或高偏倚风险;存在中等异质性(I2=45.5%),无发表偏倚证据(Harbord检验,P=.74)。

关键数值与推荐

  • 低剂量方案定义:起始剂量0.5-2毫单位/分钟,每15-40分钟增加1-2毫单位/分钟。
  • 高剂量方案定义:起始剂量≥4毫单位/分钟,每15-40分钟增加3-6毫单位/分钟。
  • 主要结局为剖宫产;次要结局包括自然阴道分娩、手术阴道分娩、引产持续时间、子宫过度刺激及母儿发病率结局。
  • 采用随机效应模型计算合并相对风险(RR)及95%置信区间(CI)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 高、低剂量方案细节在研究间差异广泛。
  • 所有纳入研究均为中等或高偏倚风险。
  • 存在中等异质性(I2=45.5%)。
  • 本综述凸显了现有少量已发表研究的方法学局限性。
  • 需要高质量试验来指导引产的最佳缩宫素剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review aimed to synthesize available literature reporting maternal and neonatal outcomes of induction of labor using high- vs low-dose oxytocin protocols. DATA SOURCES: PubMed, Embase, Scopus, CINAHL, and Cochrane databases, and ClinicalTrials.gov were searched from inception to January 17, 2023. STUDY ELIGIBILITY CRITERIA: Studies with the following criteria were included: randomized or observational studies conducted with pregnant individuals, published in English, that compared low-dose (starting dose 0.5-2 milliunits/min increased by 1-2 milliunits/min every 15-40 minutes) vs high-dose (≥4 milliunits/min increased by 3-6 milliunits/min every 15-40 minutes) oxytocin infusion protocols for induction of labor. Studies of individuals with fetal death were excluded. STUDY APPRAISAL AND SYNTHESIS METHODS: Two reviewers independently extracted data and appraised study quality following the PRISMA guidelines and using the Cochrane risk of bias assessment tools. The primary outcome was cesarean delivery. Secondary outcomes included spontaneous vaginal delivery, operative vaginal delivery, duration of labor induction, uterine tachysystole, and maternal and neonatal morbidity outcomes. Pooled relative risks (RR) with 95% confidence intervals (CI) were calculated using random-effects models. Heterogeneity was assessed statistically using the Higgins' I2 test and visually using a funnel plot. RESULTS: Six studies (two randomized controlled trials, four observational studies) were included, encompassing 7850 deliveries (3957 in the high-dose group and 3893 in the low-dose group). Overall, there was no difference in the risk of cesarean delivery following induction of labor with a high-dose oxytocin protocol compared with a low-dose protocol (26.0% vs 28.4%, pooled RR 1.02, 95% CI 0.85-1.21). There were also no differences in the likelihood of cesarean delivery for nonreassuring fetal status or neonatal morbidity, or in the duration of labor. Induction with high-dose oxytocin was associated with a lower frequency of postpartum hemorrhage, compared with a low-dose protocol (7.6% vs 9.9%, RR 0.78, 95% CI 0.66-0.92). Details of high- and low-dose protocols varied widely between studies, which all were at medium or high risk of bias. There was moderate heterogeneity (I2=45.5%), and no evidence of publication bias (Harbord test, P=.74). CONCLUSIONS: A synthesis of the existing literature demonstrates no difference in the frequency of cesarean delivery following induction of labor using a high- vs low-dose oxytocin protocol. However, this review highlights the methodological limitations of the few available published studies and the need for high-quality trials to guide optimal oxytocin dosing for labor induction. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Grasch JL, Costantine MM, Cahill AG, et al. High- vs low-dose oxytocin protocols for labor induction: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2025. PMID: 40334983. doi:10.1016/j.ajogmf.2025.101691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。